Case number 2018-1551
Amgen Inc. v. Sandoz Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | AMGEN INC. v. SANDOZ INC. [OPINION - PRECEDENTIAL] [precedential] (0) |
| Apr 23, 2021 | 0 | AMGEN INC. v. SANDOZ INC. [ORDER - NONPRECEDENTIAL] [nonprecedential] (0) |
| Sep 10, 2019 | 88 | Mandate issued to the United States District Court for the Northern District of California. Service as of this date by the Clerk of Court. [634364] [18-1551, 18-1552] [JAB] [Entered: 09/10/2019 02:21 PM] (2) |
| Sep 3, 2019 | 87 | ORDER filed. The petition for panel rehearing [77] is granted to the extent noted in this order. The petition is otherwise denied. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [632611] [MJL] [Entered: 09/03/2019 10:20 AM] (2) |
| Sep 3, 2019 | 86 | ORDER filed. The petition for panel rehearing [77] is granted in part and denied in part (see accompanying order). The petition for en banc rehearing is denied. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [632606] [MJL] [Entered: 09/03/2019 10:18 AM] (3) |
| Aug 16, 2019 | 85 | **TEXT ONLY** ORDER granting motion to withdraw attorney Bryan J. Leitch [84] filed by Appellees Sandoz GmbH, Sandoz International GmbH, Sandoz Inc. and Lek Pharmaceuticals, d.d. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [628780] [JAB] [Entered: 08/16/2019 08:57 AM] (0) |
| Aug 15, 2019 | 84 | MOTION of Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d. to withdraw counsel Bryan J. Leitch [Consent: unopposed]. Service: 08/15/2019 by email. [628649] [18-1551] [Bryan Leitch] [Entered: 08/15/2019 03:36 PM] (6) |
| Jul 30, 2019 | 83 | 18 paper copies of the response [82] received from Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. [624508] [JAB] [Entered: 07/30/2019 12:38 PM] (0) |
| Jul 29, 2019 | 82 | RESPONSE of Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d. to the petition for en banc rehearing [77] filed by Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 07/29/2019 by email. [624206] [18-1551] [Deanne Maynard] [Entered: 07/29/2019 03:07 PM] (24) |
| Jul 1, 2019 | 81 | ORDER filed granting motion to extend time to file response to rehearing/en banc [80] filed by Appellees Sandoz GmbH, Sandoz International GmbH, Sandoz Inc. and Lek Pharmaceuticals, d.d. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [617983] [JAB] [Entered: 07/01/2019 07:58 AM] (2) |
| Jun 27, 2019 | 80 | MOTION of Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d. to extend the time to file a response to the Petition for Rehearing En Banc until 07/29/2019 [Consent: unopposed]. Service: 06/27/2019 by email. [617593] [18-1551] [Deanne Maynard] [Entered: 06/27/2019 04:54 PM] (9) |
| Jun 24, 2019 | 79 | The court invites a response from Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH to the petition for en banc rehearing filed by Appellants in 18-1551. The response is due on or before 07/08/2019. [616266] [JAB] [Entered: 06/24/2019 10:03 AM] (1) |
| Jun 10, 2019 | 78 | 18 paper copies of the petition for en banc rehearing [77] received from Appellants Amgen Inc. and Amgen Manufacturing, Limited. [612747] [JAB] [Entered: 06/10/2019 12:06 PM] (0) |
| Jun 7, 2019 | 77 | Petition for en banc rehearing filed by Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 06/07/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 06/11/2019 [612573] [18-1551] [Nicholas Groombridge] [Entered: 06/07/2019 05:19 PM] (43) |
| May 30, 2019 | 76 | **TEXT ONLY** ORDER granting motion to withdraw attorney Stephen A. Maniscalco [75] filed by Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [610431] [JAB] [Entered: 05/30/2019 01:13 PM] (0) |
| May 30, 2019 | 75 | MOTION of Appellants Amgen Inc. and Amgen Manufacturing, Limited to withdraw counsel Stephen A. Maniscalco [Consent: unopposed]. Service: 05/30/2019 by email. [610408] [18-1551] [Nicholas Groombridge] [Entered: 05/30/2019 11:56 AM] (7) |
| May 8, 2019 | 74 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [605763] [18-1551, 18-1552] [PBC] [Entered: 05/08/2019 10:00 AM] (2) |
| May 8, 2019 | 73 | OPINION filed for the court by Lourie, Circuit Judge; O'Malley, Circuit Judge and Reyna, Circuit Judge. Precedential Opinion. [605762] [18-1551, 18-1552] [PBC] [Entered: 05/08/2019 09:59 AM] (16) |
| Mar 4, 2019 | 72 | Submitted after ORAL ARGUMENT by Nicholas P. Groombridge for Amgen Inc. and Amgen Manufacturing, Limited and Deanne Maynard for Sandoz GmbH, Sandoz International GmbH, Sandoz Inc. and Lek Pharmaceuticals, d.d. Panel: Judge: Lourie , Judge: O'Malley , Judge: Reyna. [590013] [JAB] [Entered: 03/04/2019 12:23 PM] (0) |
| Feb 27, 2019 | 71 | Amended Certificate of Interest for the Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d.. Service: 02/27/2019 by email. [589081] [18-1551] [Deanne Maynard] [Entered: 02/27/2019 02:13 PM] (3) |
| Feb 22, 2019 | 70 | Amended Certificate of Interest for the Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/22/2019 by email. [588078] [18-1551] [Nicholas Groombridge] [Entered: 02/22/2019 03:40 PM] (5) |
| Feb 14, 2019 | 69 | Response to notice of oral argument from the Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d.. [585859] [18-1551] [Deanne Maynard] [Entered: 02/14/2019 10:46 AM] (3) |
| Feb 13, 2019 | 68 | Response to notice of oral argument from the Appellants Amgen Inc. and Amgen Manufacturing, Limited. [585553] [18-1551] [Nicholas Groombridge] [Entered: 02/13/2019 11:17 AM] (3) |
| Jan 29, 2019 | 67 | ORDER filed denying [66] motion to file a reply filed by Amgen Inc. and Amgen Manufacturing, Limited. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [581601] [JAB] [Entered: 01/29/2019 08:56 AM] (2) |
| Jan 28, 2019 | 66 | MOTION of Appellants Amgen Inc. and Amgen Manufacturing, Limited for leave to file a response/reply to [58] response, [58] FOR CAL, [65] other document [Consent: not addressed]. Service: 01/28/2019 by email. [581378] [18-1551] [Nicholas Groombridge] [Entered: 01/28/2019 12:23 PM] (8) |
| Jan 24, 2019 | 65 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Amgen Inc. and Amgen Manufacturing, Limited, Reply to response to the supplemental authority [64], is not in compliance with the rules of this court (see attached). Compliant document due on 01/31/2019. Service as of this date by the Clerk of Court.[580409] [JAB] [Entered: 01/24/2019 09:41 AM] (1) |
| Jan 23, 2019 | 64 | REPLY of Appellants Amgen Inc. and Amgen Manufacturing, Limited to response filed by Appellees, Doc. No [58]. Service: 01/23/2019 by email. [580348] [18-1551] This document is non-compliant. See Doc. No. [65]. [Nicholas Groombridge] [Entered: 01/23/2019 07:20 PM] (3) |
| Jan 22, 2019 | 63 | NOTICE OF ORAL ARGUMENT. Panel: 1903D. Case scheduled Mar 04, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 02/15/2019. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [579712] [JAB] [Entered: 01/22/2019 01:30 PM] (2) |
| Jan 11, 2019 | 62 | **TEXT ONLY** ORDER granting motion to withdraw attorney [61] Arielle Linsey filed by Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [577742] [SJ] [Entered: 01/11/2019 02:49 PM] (0) |
| Jan 11, 2019 | 61 | MOTION of Appellants Amgen Inc. and Amgen Manufacturing, Limited to withdraw counsel Arielle K. Linsey [Consent: unopposed]. Service: 01/11/2019 by email. [577585] [18-1551] [Nicholas Groombridge] [Entered: 01/11/2019 11:00 AM] (6) |
| Dec 21, 2018 | 60 | Notice from Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH regarding conflicts with oral argument. Service: 12/21/2018 by email. [573919] [18-1551] [Deanne Maynard] [Entered: 12/21/2018 10:27 AM] (2) |
| Dec 19, 2018 | 59 | Amended Certificate of Interest for the Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 12/19/2018 by email. [572984] [18-1551] [Nicholas Groombridge] [Entered: 12/19/2018 11:22 AM] (4) |
| Dec 10, 2018 | 58 | RESPONSE of Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d. to the supplemental authority [57] filed by Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 12/10/2018 by email. [570550] [18-1551] [Deanne Maynard] [Entered: 12/10/2018 02:54 PM] (3) |
| Nov 26, 2018 | 57 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 11/26/2018 by email. [567542] [18-1551] [Nicholas Groombridge] [Entered: 11/26/2018 03:50 PM] (55) |
| Oct 11, 2018 | 56 | Notice from Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH regarding conflicts with oral argument (Sandoz respectfully requests that the argument not be scheduled for January 7-11, March 6-8, or April 1-3.). Service: 10/11/2018 by email. [556381] [18-1551] [Deanne Maynard] [Entered: 10/11/2018 01:38 PM] (2) |
| Aug 2, 2018 | 55 | Notice from Appellees Sandoz International GmbH, Sandoz Inc., Sandoz GmbH and Lek Pharmaceuticals, d.d. regarding conflicts with oral argument (Sandoz respectfully requests that the argument not be scheduled for October 1-3 or November 5-9. Sandoz is available October 4-5, December 3-7, or January 7-11.). Service: 08/02/2018 by email. [540432] [18-1551] [Deanne Maynard] [Entered: 08/02/2018 01:27 PM] (2) |
| Aug 2, 2018 | 54 | 6 paper copies of the Confidential Joint Appendix Brief (Vol. I - III) [50] received from Appellants Amgen Inc. and Amgen Manufacturing, Limited. [540380] [CJF] [Entered: 08/02/2018 10:40 AM] (0) |
| Aug 1, 2018 | 53 | Notice from Appellants Amgen Inc. and Amgen Manufacturing, Limited regarding conflicts with oral argument (Amgen respectfully requests that oral argument not be set for August 6-10, 2018, September 4-7, 2018, October 2-4, 2018, December 3-7, 2018, and January 7-8, 2019. Amgen is available October 1 and 5, 2018, November 5-9, 2018, and January 9-11, 2019.). Service: 08/01/2018 by email. [540277] [18-1551] [Nicholas Groombridge] [Entered: 08/01/2018 05:20 PM] (2) |
| Jul 31, 2018 | 52 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category.. [539616] [SJ] [Entered: 07/31/2018 09:56 AM] (0) |
| Jul 27, 2018 | 46 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Amgen Inc., Amgen Manufacturing, Limited and Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d.. Service: 07/27/2018 by email. [539225] [18-1551] [Nicholas Groombridge] [Entered: 07/27/2018 06:33 PM] (3) |
| Jul 27, 2018 | 47 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Amgen Inc., Amgen Manufacturing, Limited and Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d.. Service: 07/27/2018 by email. [539227] [18-1551] [Nicholas Groombridge] [Entered: 07/27/2018 06:36 PM] (3) |
| Jul 27, 2018 | 48 | TENDERED from Appellants Amgen Inc., Amgen Manufacturing, Limited and Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Title: JOINT APPENDIX. Service: 07/27/2018 by email. [539237] [18-1551] [Nicholas Groombridge] [Entered: 07/27/2018 07:37 PM] (1558) |
| Jul 27, 2018 | 49 | TENDERED from Appellants Amgen Inc., Amgen Manufacturing, Limited and Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Title: CONFIDENTIAL JOINT APPENDIX Service: 07/27/2018 by email. [539238] [18-1551] [Nicholas Groombridge] [Entered: 07/27/2018 07:43 PM] (0) |
| Jul 27, 2018 | 50 | CONFIDENTIAL JOINT APPENDIX FILED (3 vols.) for Amgen Inc. and Amgen Manufacturing, Limited [49]. Number of Pages: 1596. Service: 07/27/2018 by email. The paper copies of the brief should be received by the court on or before 08/07/2018. [539607] [SJ] [Entered: 07/31/2018 09:46 AM] (0) |
| Jul 27, 2018 | 51 | APPENDIX FILED (3 vols.) for Amgen Inc. and Amgen Manufacturing, Limited [48]. Number of Pages: 1554. Service: 07/27/2018 by email. [539613] [SJ] [Entered: 07/31/2018 09:54 AM] (1558) |
| Jul 26, 2018 | 45 | 6 paper copies of the Confidential Reply Brief [43] received from Appellants Amgen Inc. and Amgen Manufacturing, Limited. [538691] [CJF] [Entered: 07/26/2018 11:13 AM] (0) |
| Jul 23, 2018 | 44 | REPLY BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing, Limited [42]. Number of Pages: 32. Service: 07/20/2018 by email. Appendix is due 07/27/2018. [537744] [SJ] [Entered: 07/23/2018 01:43 PM] (41) |
| Jul 20, 2018 | 41 | TENDERED from Appellants Amgen Inc. and Amgen Manufacturing, Limited. Title: CONFIDENTIAL REPLY BRIEF Service: 07/20/2018 by email. [537531] [18-1551] [Nicholas Groombridge] [Entered: 07/20/2018 07:13 PM] (0) |
| Jul 20, 2018 | 42 | TENDERED from Appellants Amgen Inc. and Amgen Manufacturing, Limited. Title: REPLY BRIEF. Service: 07/20/2018 by email. [537532] [18-1551] [Nicholas Groombridge] [Entered: 07/20/2018 07:15 PM] (41) |
| Jul 20, 2018 | 43 | CONFIDENTIAL REPLY BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing, Limited [41]. Number of Pages: 32. Service: 07/20/2018 by email. The paper copies of the brief should be received by the court on or before 07/30/2018. [537742] [SJ] [Entered: 07/23/2018 01:41 PM] (0) |
| Jun 29, 2018 | 40 | **TEXT ONLY** ORDER granting motion to extend time to file brief [39] filed by Appellants Amgen Inc. and Amgen Manufacturing, Limited. The reply brief is due 07/20/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [532857] [CFT] [Entered: 06/29/2018 02:13 PM] (0) |
| Jun 29, 2018 | 39 | MOTION of Appellants Amgen Inc. and Amgen Manufacturing, Limited to extend the time to 07/20/2018 to file the Reply Brief. [Consent: unopposed]. Service: 06/29/2018 by email. [532731] [18-1551] [Nicholas Groombridge] [Entered: 06/29/2018 10:37 AM] (6) |
| Jun 26, 2018 | 38 | 6 paper copies of the Confidential Opening Response Brief [36] received from Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. [531988] [CJF] [Entered: 06/26/2018 01:18 PM] (0) |
| Jun 22, 2018 | 37 | BRIEF FILED for Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH [35]. Number of Pages: 66. Service: 06/22/2018 by email. Appellants Amgen Inc. and Amgen Manufacturing, Limited reply brief is due 07/06/2018. [531723] [SJ] [Entered: 06/25/2018 02:22 PM] (79) |
| Jun 22, 2018 | 36 | CONFIDENTIAL BRIEF FILED for Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH [34]. Number of Pages: 66. Service: 06/22/2018 by email. The paper copies of the brief should be received by the court on or before 07/02/2018. [531719] [SJ] [Entered: 06/25/2018 02:20 PM] (0) |
| Jun 22, 2018 | 35 | TENDERED from Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d.. Title: RESPONSE BRIEF. Service: 06/22/2018 by email. [531527] [18-1551] [Deanne Maynard] [Entered: 06/22/2018 05:34 PM] (79) |
| Jun 22, 2018 | 34 | TENDERED from Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 06/22/2018 by email. [531526] [18-1551] [Deanne Maynard] [Entered: 06/22/2018 05:31 PM] (0) |
| May 17, 2018 | 33 | ORDER filed. The motion [31] is granted. The appellees' response brief is due June 22, 2018. Service: 05/17/2018 by clerk. [522606] [LMS] [Entered: 05/17/2018 03:42 PM] (2) |
| May 11, 2018 | 32 | RESPONSE of Appellants Amgen Inc. and Amgen Manufacturing, Limited to the motion to extend time to file brief [31] filed by Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d.. Service: 05/11/2018 by email. [521146] [18-1551] [Nicholas Groombridge] [Entered: 05/11/2018 03:42 PM] (7) |
| May 11, 2018 | 31 | MOTION of Appellees Sandoz Inc., Sandoz International GmbH, Sandoz GmbH and Lek Pharmaceuticals, d.d. to extend the time to 06/22/2018 to file the answering brief. [Consent: opposed]. Service: 05/11/2018 by email. [521064] [18-1551] [Deanne Maynard] [Entered: 05/11/2018 01:11 PM] (10) |
| Apr 27, 2018 | 30 | 6 paper copies of the Confidential Opening Brief [28] received from Appellants Amgen Inc. and Amgen Manufacturing, Limited. [517290] [JCP] [Entered: 04/27/2018 12:04 PM] (0) |
| Apr 13, 2018 | 29 | BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing, Limited [27]. Number of Pages: 70. Service: 04/13/2018 by email. Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH brief is due 05/23/2018. [516361] [SJ] [Entered: 04/24/2018 11:52 AM] (167) |
| Apr 13, 2018 | 28 | CONFIDENTIAL BRIEF FILED for Appellants Amgen Inc. and Amgen Manufacturing, Limited [26]. Number of Pages: 70. Service: 04/13/2018 by email. The paper copies of the brief should be received by the court on or before 05/01/2018. [516356] [SJ] [Entered: 04/24/2018 11:50 AM] (0) |
| Apr 13, 2018 | 27 | TENDERED from Appellants Amgen Inc. and Amgen Manufacturing, Limited. Title: OPENING BRIEF. Service: 04/13/2018 by email. [513469] [18-1551] [Nicholas Groombridge] [Entered: 04/13/2018 09:58 PM] (167) |
| Apr 13, 2018 | 26 | TENDERED from Appellants Amgen Inc. and Amgen Manufacturing, Limited. Title: CONFIDENTIAL OPENING BRIEF Service: 04/13/2018 by email. [513468] [18-1551] [Nicholas Groombridge] [Entered: 04/13/2018 09:57 PM] (0) |
| Feb 26, 2018 | 25 | Docketing Statement for the Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/26/2018 by email. [501138] [Nicholas Groombridge] [Entered: 02/26/2018 03:56 PM] (5) |
| Feb 26, 2018 | 24 | Entry of appearance for Eric C. Pai as of counsel for Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Service: 02/26/2018 by email. [501124] [Eric Pai] [Entered: 02/26/2018 03:32 PM] (2) |
| Feb 26, 2018 | 23 | Entry of appearance for Erik J. Olson as of counsel for Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Service: 02/26/2018 by email. [501105] [Erik Olson] [Entered: 02/26/2018 03:15 PM] (2) |
| Feb 26, 2018 | 22 | Entry of appearance for Bryan J. Leitch as of counsel for Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Service: 02/26/2018 by email. [501099] [Bryan Leitch] [Entered: 02/26/2018 03:10 PM] (2) |
| Feb 26, 2018 | 21 | Entry of appearance for Brian R. Matsui as of counsel for Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Service: 02/26/2018 by email. [501098] [Brian Matsui] [Entered: 02/26/2018 03:09 PM] (2) |
| Feb 26, 2018 | 20 | Docketing Statement for the Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Service: 02/26/2018 by email. [501096] [Deanne Maynard] [Entered: 02/26/2018 03:07 PM] (4) |
| Feb 26, 2018 | 19 | Certificate of Interest for the Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Service: 02/26/2018 by email. [501095] [Deanne Maynard] [Entered: 02/26/2018 03:06 PM] (3) |
| Feb 26, 2018 | 18 | Entry of appearance for Deanne E. Maynard as principal counsel for Appellees Lek Pharmaceuticals, d.d., Sandoz GmbH, Sandoz Inc. and Sandoz International GmbH. Service: 02/26/2018 by email. [501093] [Deanne Maynard] [Entered: 02/26/2018 03:05 PM] (2) |
| Feb 23, 2018 | 17 | Entry of appearance for Golda Lai as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/23/2018 by email. [500610] [Nicholas Groombridge] [Entered: 02/23/2018 10:35 AM] (2) |
| Feb 23, 2018 | 16 | Entry of appearance for Eric Alan Stone as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/23/2018 by email. [500608] [Nicholas Groombridge] [Entered: 02/23/2018 10:33 AM] (2) |
| Feb 23, 2018 | 15 | Entry of appearance for Wendy A. Whiteford as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/23/2018 by email. [500603] [Nicholas Groombridge] [Entered: 02/23/2018 10:29 AM] (2) |
| Feb 20, 2018 | 14 | Certificate of Compliance with Fed. R. App. P. 10(b) [The Transcript of Proceedings] for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/20/2018 by email. [499531] [Nicholas Groombridge] [Entered: 02/20/2018 05:39 PM] (3) |
| Feb 20, 2018 | 13 | Certificate of Interest for the Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/20/2018 by email. [499530] [Nicholas Groombridge] [Entered: 02/20/2018 05:38 PM] (3) |
| Feb 20, 2018 | 12 | Entry of appearance for Jacob Whitt as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/20/2018 by email. [499529] [Nicholas Groombridge] [Entered: 02/20/2018 05:37 PM] (2) |
| Feb 20, 2018 | 11 | Entry of appearance for Arielle K. Linsey as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/20/2018 by email. [499527] [Nicholas Groombridge] [Entered: 02/20/2018 05:35 PM] (2) |
| Feb 20, 2018 | 10 | Entry of appearance for Kimberlin L. Morley as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/20/2018 by email. [499526] [Nicholas Groombridge] [Entered: 02/20/2018 05:33 PM] (2) |
| Feb 16, 2018 | 9 | Entry of appearance for Stephen A. Maniscalco as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/16/2018 by email. [499143] [Nicholas Groombridge] [Entered: 02/16/2018 08:05 PM] (2) |
| Feb 16, 2018 | 8 | Entry of appearance for Peter Sandel as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/16/2018 by email. [499140] [Nicholas Groombridge] [Entered: 02/16/2018 07:56 PM] (2) |
| Feb 16, 2018 | 7 | Entry of appearance for Jennifer Gordon as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/16/2018 by email. [499139] [Nicholas Groombridge] [Entered: 02/16/2018 07:55 PM] (2) |
| Feb 16, 2018 | 6 | Entry of appearance for Jennifer H. Wu as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/16/2018 by email. [499138] [Nicholas Groombridge] [Entered: 02/16/2018 07:52 PM] (2) |
| Feb 16, 2018 | 5 | Entry of appearance for Lois M. Kwasigroch as of counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/16/2018 by email. [499137] [Nicholas Groombridge] [Entered: 02/16/2018 07:47 PM] (2) |
| Feb 16, 2018 | 4 | Entry of appearance for Nicholas Groombridge as principal counsel for Appellants Amgen Inc. and Amgen Manufacturing, Limited. Service: 02/16/2018 by email. [499136] [Nicholas Groombridge] [Entered: 02/16/2018 07:44 PM] (2) |
| Feb 16, 2018 | 3 | Note to file: The following cases are associated:18-1551 (lead) with 18-1552 (consol.). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [499013] [18-1551, 18-1552] [SJ] [Entered: 02/16/2018 02:04 PM] (0) |
| Feb 16, 2018 | 2 | ORDER consolidating appeals (18-1551 & 18-1552). Service as of this date by Clerk of Court. [499012] [18-1551, 18-1552] [SJ] [Entered: 02/16/2018 02:02 PM] (2) |
| Feb 12, 2018 | 1 | Appeal docketed. Received: 02/06/2018. [497056]Entry of Appearance due 02/26/2018. Certificate of Interest is due on 02/26/2018. Docketing Statement due 02/26/2018. Appellant/Petitioner's brief is due 04/13/2018. [SJ] [Entered: 02/12/2018 01:42 PM] (157) |
